1209 related articles for article (PubMed ID: 34528143)
1. The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities.
Mehraj U; Ganai RA; Macha MA; Hamid A; Zargar MA; Bhat AA; Nasser MW; Haris M; Batra SK; Alshehri B; Al-Baradie RS; Mir MA; Wani NA
Cell Oncol (Dordr); 2021 Dec; 44(6):1209-1229. PubMed ID: 34528143
[TBL] [Abstract][Full Text] [Related]
2. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
Dzobo K
OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
[TBL] [Abstract][Full Text] [Related]
3. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
[TBL] [Abstract][Full Text] [Related]
4. Cancer associated-fibroblast-derived exosomes in cancer progression.
Li C; Teixeira AF; Zhu HJ; Ten Dijke P
Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
[TBL] [Abstract][Full Text] [Related]
5. Tumor microenvironment-based screening repurposes drugs targeting cancer stem cells and cancer-associated fibroblasts.
Lee PJ; Ho CC; Ho H; Chen WJ; Lin CH; Lai YH; Juan YC; Chu WC; Lee JH; Su SF; Chen HY; Chen JJW; Chang GC; Li KC; Yang PC; Chen HW
Theranostics; 2021; 11(19):9667-9686. PubMed ID: 34646392
[TBL] [Abstract][Full Text] [Related]
6. Cancer-associated fibroblasts as key regulators of the breast cancer tumor microenvironment.
Houthuijzen JM; Jonkers J
Cancer Metastasis Rev; 2018 Dec; 37(4):577-597. PubMed ID: 30465162
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk and plasticity driving between cancer-associated fibroblasts and tumor microenvironment: significance of breast cancer metastasis.
Zhang W; Wang J; Liu C; Li Y; Sun C; Wu J; Wu Q
J Transl Med; 2023 Nov; 21(1):827. PubMed ID: 37978384
[TBL] [Abstract][Full Text] [Related]
8. The role of tumor-associated macrophage in breast cancer biology.
Choi J; Gyamfi J; Jang H; Koo JS
Histol Histopathol; 2018 Feb; 33(2):133-145. PubMed ID: 28681373
[TBL] [Abstract][Full Text] [Related]
9. Tumor microenvironment promotes breast cancer chemoresistance.
Mehraj U; Dar AH; Wani NA; Mir MA
Cancer Chemother Pharmacol; 2021 Feb; 87(2):147-158. PubMed ID: 33420940
[TBL] [Abstract][Full Text] [Related]
10. Intimate communications within the tumor microenvironment: stromal factors function as an orchestra.
Cheng B; Yu Q; Wang W
J Biomed Sci; 2023 Jan; 30(1):1. PubMed ID: 36600243
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
12. Diversity and Biology of Cancer-Associated Fibroblasts.
Biffi G; Tuveson DA
Physiol Rev; 2021 Jan; 101(1):147-176. PubMed ID: 32466724
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer.
Kundu M; Butti R; Panda VK; Malhotra D; Das S; Mitra T; Kapse P; Gosavi SW; Kundu GC
Mol Cancer; 2024 May; 23(1):92. PubMed ID: 38715072
[TBL] [Abstract][Full Text] [Related]
14. CAF-immune cell crosstalk and its impact in immunotherapy.
Maia A; Schöllhorn A; Schuhmacher J; Gouttefangeas C
Semin Immunopathol; 2023 Mar; 45(2):203-214. PubMed ID: 36480035
[TBL] [Abstract][Full Text] [Related]
15. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.
Zhu Y; Li X; Wang L; Hong X; Yang J
Front Endocrinol (Lausanne); 2022; 13():988295. PubMed ID: 36046791
[TBL] [Abstract][Full Text] [Related]
16. Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer.
Deepak KGK; Vempati R; Nagaraju GP; Dasari VR; S N; Rao DN; Malla RR
Pharmacol Res; 2020 Mar; 153():104683. PubMed ID: 32050092
[TBL] [Abstract][Full Text] [Related]
17. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
Eskandari-Malayeri F; Rezaei M
Front Immunol; 2022; 13():996145. PubMed ID: 36275750
[TBL] [Abstract][Full Text] [Related]
18. Cellular interactions in tumor microenvironment during breast cancer progression: new frontiers and implications for novel therapeutics.
Akinsipe T; Mohamedelhassan R; Akinpelu A; Pondugula SR; Mistriotis P; Avila LA; Suryawanshi A
Front Immunol; 2024; 15():1302587. PubMed ID: 38533507
[TBL] [Abstract][Full Text] [Related]
19. The Microenvironment of Lung Cancer and Therapeutic Implications.
Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH
Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800
[TBL] [Abstract][Full Text] [Related]
20. Active autophagy in cancer-associated fibroblasts: Recent advances in understanding the novel mechanism of tumor progression and therapeutic response.
Jena BC; Rout L; Dey A; Mandal M
J Cell Physiol; 2021 Nov; 236(11):7887-7902. PubMed ID: 34008184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
